Quality by design in formulation and process development for a freeze-dried, small molecule parenteral product: a case study

By Mockus Linas N.   Paul Timothy W.   Pease Nathan A.   Harper Nancy J.   Basu Prabir K.   Oslos Elizabeth A.   Sacha Gregory A.   Kuu Wei Y.   Hardwick Lisa M.   Karty Jacquelyn J.   Pikal Michael J.   Hee Eun   Khan Mansoor A.   Nail Steven L.  

Pharmaceutical Development and Technology, Vol. 16, Iss. 6, 2011-12 ,pp. : 549-576

Informa Healthcare

Access to resources Recommend Favorite

Standardization of Procedures for the Preparation of ¹⁷⁷Lu- and ⁹⁰Y-labeled DOTA-Rituximab Based on the Freeze-dried Kit Formulation

By  

Current Radiopharmaceuticals, Vol. 8, Iss. 1, 2015-05 ,pp. : 62-68

Bentham Science Publishers

Access to resources Recommend Favorite

A bivalent human papillomavirus (HPV)-16/18 L1 virus-like particle AS04 vaccine may not increase viral clearance

By  

Inpharma, Vol. 1, Iss. 1601, 2007-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Development of freeze-dried biosynthetic Factor VIII: I. A case study in the optimization of formulation

By Jameel Feroz   Tchessalov Serguei   Bjornson Erik   Lu Xiaofeng   Besman Marc   Pikal Michael  

Pharmaceutical Development and Technology, Vol. 14, Iss. 6, 2009-12 ,pp. : 687-697

Informa Healthcare

Access to resources Recommend Favorite

A Systems Biology Perspective on Rational Design of Peptide Vaccine Against Virus Infections

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 12, 2012-06 ,pp. : 1310-1319

Bentham Science Publishers

Access to resources Recommend Favorite